
Abbott Laboratories (NYSE:ABT)

Intrinsic Value
The intrinsic value of one
ABT
stock under the Base Case scenario is
95.84
USD.
Compared to the current market price of 106.97 USD,
Abbott Laboratories
is
Overvalued by 10%.
The Intrinsic Value is calculated as the average of the two valuation methods:

Fundamental Analysis
ABT Profitability Score
Profitability Due Diligence
Abbott Laboratories's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Abbott Laboratories's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
ABT Solvency Score
Solvency Due Diligence
Abbott Laboratories's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Abbott Laboratories's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall Street
Price Targets
ABT Price Targets
Price Targets made by Wall Street
12-month price targets for ABT stock made by Wall Street professionals. The average price target is 142.08 USD with a low forecast of 112.11 USD and a high forecast of 166.43 USD.
Insider Trading
ABT Insider Trading
Buy and sell transactions by insiders
During the last 3 months Abbott Laboratories insiders have not bought any shares, and sold 8.4M USD worth of shares. The last transaction was made on May 4, 2022 by Randel William Woodgrift, who sold 2.7M USD worth of ABT shares.
Company Profile

Country
Industry
Market Cap
Dividend Yield
Description
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 113,000 full-time employees. The firm operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.
Contact
IPO
Employees
Officers
ABT Stock FAQ
The intrinsic value of one
ABT
stock under the Base Case scenario is
95.84
USD.
Compared to the current market price of 106.97 USD, Abbott Laboratories is Overvalued by 10%.